HR 2114 United States House · 119th Congress

Block Organ Transplant Purchases from China Act of 2025

This bill prohibits federal health programs (Medicare, Medicaid) and private health insurance from covering organ transplants originating in China or not procured through the U.S. Organ Procurement Network, effective January 1, 2026. It defines a "prohibited organ transplant" as one performed in China or using organs not sourced via the U.S. network, including follow-up care like lab tests or drugs. Exceptions only apply to life-saving services provided *after* such a transplant. The law also imposes criminal penalties (up to 2 years in prison) and civil penalties (three times the cost) for violations.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
President
Introduced Mar 14, 2025 Last action Mar 14, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 14, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Mar 14, 2025
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors

Sponsors